²é¿´: 550  |  »Ø¸´: 3

wangyubobby

¾èÖú¹ó±ö (СÓÐÃûÆø)

[½»Á÷] ¡¾½»Á÷¡¿´Ó·¢±íÂÛÎÄˮƽ¿´Ëãʲôˮƽ¡£¡£ÐÂÊÖÇóÖú ÒÑÓÐ2È˲ÎÓë

Books/Book Chapters

1. Xu, Wenfang; Zhao, Guisen; Zhang, Shijun. ¡°The Principles and Methods of New Drug Design¡± 1st Edition, China Medical Science and Technology Publishing House, Jul. 1997 2. Xu, Wenfang; Zhao, Guisen; Zhang, Shijun. ¡°The Principles and Methods of New Drug Design¡± 2d Edition, Science Publishing House, Oct. 2000
Recent Publications

Lenhart, J.A.; Ling, X.; Gandhi, R.; Guo, T.L.; Gerk, P.M.; Brunzell, D.H.; Zhang, S. "Clicked" Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional Abeta Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization. J. Med. Chem. 2010, 53, 6198-6209.
Li, Q.; Wu, J.; Zheng, H.; Liu, K.; Guo, T.L.; Liu, Y.; Eblen, S.T.; Grant, S.; Zhang, Shijun. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg. & Med. Chem. Lett. 2010, 20, 4526-4530.
Zhang, Shijun; Yekkirala, Ajay; Tang, Ye; Portoghese, Philip S. A bivalent ligand (KMN-21) antagonist for µ/? heterodimeric opioid receptors. Bioorg & Med. Chem. Lett. 2009, 19, 6978-6980.
Li, Qianbin; Al-Ayoubi, Adnan; Guo, Tailiang; Zheng, Hui; Sarkar, Aurijit; Nguyen, Tri; Eblen, Scott T.; Grant, Steven; Kellogg, Glen E.; Zhang, Shijun. Structure-activity relationship (SAR) studies of 3-(2- amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: Development of potential substrate-specific ERK1/2 inhibitors. Bioorg & Med. Chem. Lett. 2009, 19, 6042-6046.
Zhang, Shijun; Fernandez, Fernando; Zhen, Juan; Reith, Maarten E. A.; Dutta, Aloke K.. Further structural exploration of tri-substituted asymmetric pyran derivaives, (2S, 4R, 5R)-2-benzhydryl-5- benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S, 6S)-pyran derivatives: A proposed pharmacohpore model for high affinity interaction with the dopamine, serotonin, and norepinephrine transporters. J. Med. Chem. 2006, 49, 4239-4237.
Zhang, Shijun; Zhen, Juan; Reith, Maarten E. A.; Dutta, Aloke K.. Design, Synthesis, and Preliminary SAR Study of 3-and 6-Sides-Chain Extended Tetrahydro-Pyran Analogues of cis- and trans-(6- benzhydryl-piperidin-3-yl)-benzylamine. Bioorg. & Med. Chem. 2006, 14, 3953- 3966.
Zhang, Shijun; Zhen, Juan; Reith, Maarten E.A.; Dutta, Aloke K.. Discovery of novel tri-substituted asymmetric pyran derivatives, (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner. J. Med. Chem. 2005, 48, 4962-4971.
Zhang, Shijun; Zhen, Juan; Reith, Maarten E.A.; Dutta, Aloke K.. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters. Bioorg. & Med. Chem. 2004, 12, 6301- 6315.
Dutta, Aloke K.; Venkataraman, Sylesh K.; Fei, Xiang-shu; Kolhatkar, Rohit; Zhang, Shijun; Reith,Maarten E.A.. Synthesis and biological characterization of novel hybrid 7-{[2-(4-phenylpiperazin- 1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol analogues for the dopamine D2 and D3 receptors. Bioorg. & Med. Chem. 2004, 12, 4361- 4373.
Dutta, Aloke K.; Zhang, Shijun; Kohhatkar, Rohit; Reith, Maarten E.A.. Dopamine Transporter as Target for Drug Development of Cocaine Dependence Medications. Europ. J. Pharmacol. 2003, 479, 93-106.
Zhang, Shijun; Reith, Maarten E.A.; Dutta, Aloke K.. Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter. Bioorg. & Med. Chem. Lett. 2003, 13, 1591-1595.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jiangchunyong

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Ö÷ÒªÊÇBMCºÍJMC ÔÚÒ©»¯·½ÃæÒ»°ã°É
2Â¥2011-03-27 21:41:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangyubobby

¾èÖú¹ó±ö (СÓÐÃûÆø)

ÒýÓûØÌû:
Originally posted by jiangchunyong at 2011-03-27 21:41:06:
Ö÷ÒªÊÇBMCºÍJMC ÔÚÒ©»¯·½ÃæÒ»°ã°É

---ˮƽһ°ã°¡¡£¡£¡£ËûÊÇVirginia Commonwealth University
Department of Medicinal Chemistry    ²»ÊÇÖ÷¹¥Ò©»¯Âð
3Â¥2011-03-27 21:45:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jiangchunyong

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÊÇÒ©»¯µÄѽ ¾ÍÊÇÒ»°ã°¡
4Â¥2011-03-27 21:48:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ wangyubobby µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] ͶƱ:  ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿ +16 °®¿´ÊéµÄ¿ÉÀÖ 2026-08-26 18/900 2026-08-29 00:28 by winsaint
[»ù½ðÉêÇë] ¹ú×ÔÈ»ÆÀÉóÒâ¼û +11 wangmingqi 2026-08-28 15/750 2026-08-29 00:17 by fangyl2005
[»ù½ðÉêÇë] Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ +12 Kittylucky 2026-08-27 13/650 2026-08-29 00:04 by superceng
[»ù½ðÉêÇë] ¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶Ó­ÌÖÂÛ (½ð±Ò+15) +13 ÇçÌì¼ÓÓÍ 2026-08-26 14/700 2026-08-28 18:36 by huagongfeihu
[»ù½ðÉêÇë] ÓÐûÓÐÈÔûÊÕµ½ÐÅÏ¢µÄ +3 µÂÉÐÖÐÐÐ 2026-08-27 3/150 2026-08-28 15:24 by rongshuxia
[»ù½ðÉêÇë] »ù½ð²»ÖУ¬¹²Ãã +11 eulota 2026-08-26 11/550 2026-08-28 14:22 by »ðÐdz¬ÈËxi
[»ù½ðÉêÇë] »ù½ðϵͳʲôÄÚÈÝҲûÓÐ 30+4 winsaint 2026-08-27 9/450 2026-08-28 11:06 by maolC
[»ù½ðÉêÇë] Ôõô²é°¡ +6 huang1991js 2026-08-26 6/300 2026-08-28 08:42 by winsaint
[»ù½ðÉêÇë] ÄÄλ¸ßÈËÖÐÁË£¬°Ñ²éѯµ½µÄ½ØÍ¼Ìù³öÀ´ÈÃÎÒ¿´¿´£¬ÈÃÎÒ³¤³¤¼ûʶ +5 yuleib84 2026-08-26 6/300 2026-08-28 00:02 by yudaoqian88
[»ù½ðÉêÇë] ¿´°åÉÏÕâô¶àÖеģ¬ÓеãÏñ50ÈËȺÀï49¸öÈ˶¼ÊÇÆ­×ÓµÄÄÇÖָоõ¡­¡­ +5 a089 2026-08-26 6/300 2026-08-27 14:05 by jonewore
[ÎÄѧ·¼²ÝÔ°] ÃÎÏë +3 myrtle 2026-08-26 3/150 2026-08-27 10:01 by angelyueyi
[»ù½ðÉêÇë] ÎÒ²»Àí½â£¡ +15 Edward_pc 2026-08-26 23/1150 2026-08-26 20:34 by zzuzxg
[»ù½ðÉêÇë] 2026ÄêµÄ¹ú¼ÒÉç¿Æ»ù½ðÏîĿͨѶÆÀÉóµÄйæÔòÓëж¯Ïò¡¢ÐÂÌôÕ½ +7 process2012 2026-08-23 10/500 2026-08-26 19:23 by hmhminy
[»ù½ðÉêÇë] ·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë +9 Ñ׻ƹóëÐ 2026-08-22 10/500 2026-08-26 15:40 by semaglutide
[»ù½ðÉêÇë] Ϊʲô¹ú×ÔÈ»²»ÄÜÖ±½Ó¹«²¼ +4 bjdxyxy 2026-08-26 4/200 2026-08-26 13:12 by qingmu1201
[»ù½ðÉêÇë] ¹úºÏÀïÃæÄÜ¿´µ½ÁË +7 Ò»»³Ü°Çï 2026-08-26 7/350 2026-08-26 11:23 by zhaosm1982
[»ù½ðÉêÇë] ¹ú¼ÊºÏ×÷¿É²éÁË£¬ÖÐÁËÃæÉÏ (EPI+1)(½ð±Ò+50) +18 Ldrop2023 2026-08-26 18/900 2026-08-26 11:15 by cmrandy
[Ö°³¡ÈËÉú] ѧÉúײ¼û¸¨µ¼Ô±ËÍÍâÂô£¬µÚ¶þÌìÈ«°à¶¼³ÁĬÁË +3 ¾¨ÓãÈÚ½ð_Õã½­_É 2026-08-22 3/150 2026-08-26 09:01 by zzuzxg
[»ù½ðÉêÇë] Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿ +6 chengyan1220 2026-08-23 6/300 2026-08-25 19:45 by zfd97
[»ù½ðÉêÇë] ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË +9 ͼÀ²Í¼À² 2026-08-24 10/500 2026-08-25 11:59 by ÄϺ£Ð¡¸ç
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û